IL1B and systemic sclerosis: Upon stratification of the SSc cohort into low and high serum IL‐1β subsets according to median IL‐1β concentration (7.1 pg mL−1), we observed that mRSS was statistically significantly higher in patients with high serum IL‐1β than in those without (Figure 3c and Supplementary table 6).